Cocrystal Long Term Investments vs Retained Earnings Analysis

COCP Stock  USD 1.83  0.06  3.17%   
Cocrystal Pharma financial indicator trend analysis is way more than just evaluating Cocrystal Pharma prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cocrystal Pharma is a good investment. Please check the relationship between Cocrystal Pharma Long Term Investments and its Retained Earnings accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.

Long Term Investments vs Retained Earnings

Long Term Investments vs Retained Earnings Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cocrystal Pharma Long Term Investments account and Retained Earnings. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Cocrystal Pharma's Long Term Investments and Retained Earnings is 0.56. Overlapping area represents the amount of variation of Long Term Investments that can explain the historical movement of Retained Earnings in the same time period over historical financial statements of Cocrystal Pharma, assuming nothing else is changed. The correlation between historical values of Cocrystal Pharma's Long Term Investments and Retained Earnings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Investments of Cocrystal Pharma are associated (or correlated) with its Retained Earnings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Retained Earnings has no effect on the direction of Long Term Investments i.e., Cocrystal Pharma's Long Term Investments and Retained Earnings go up and down completely randomly.

Correlation Coefficient

0.56
Relationship DirectionPositive 
Relationship StrengthWeak

Long Term Investments

Long Term Investments is an item on the asset side of Cocrystal Pharma balance sheet that represents investments Cocrystal Pharma intends to hold for over a year. Cocrystal Pharma long term investments may include different instruments such as stocks, bonds, real estate and cash.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.
Most indicators from Cocrystal Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cocrystal Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.At this time, Cocrystal Pharma's Enterprise Value Over EBITDA is relatively stable compared to the past year. As of 02/08/2025, Enterprise Value Multiple is likely to grow to 0.39, while Issuance Of Capital Stock is likely to drop slightly above 3.4 M.
 2022 2023 2024 2025 (projected)
Total Operating Expenses18.1M22.5M25.9M21.6M
Cost Of Revenue241.6K15.2K13.7K13.0K

Cocrystal Pharma fundamental ratios Correlations

0.170.590.020.190.22-0.080.96-0.41-0.070.56-0.09-0.150.77-0.10.570.3-0.42-0.3-0.4-0.44-0.160.660.41-0.450.34
0.17-0.310.430.610.03-0.410.250.04-0.410.12-0.36-0.640.46-0.360.150.860.140.43-0.030.16-0.370.30.770.130.84
0.59-0.31-0.2-0.190.470.140.53-0.670.140.680.140.46-0.060.10.68-0.22-0.38-0.27-0.31-0.510.090.51-0.24-0.49-0.28
0.020.43-0.20.750.02-0.980.25-0.14-0.980.1-0.79-0.650.2-0.970.140.280.01-0.14-0.330.480.280.340.270.450.46
0.190.61-0.190.75-0.14-0.770.37-0.13-0.760.16-0.49-0.910.4-0.770.250.47-0.12-0.16-0.460.59-0.240.350.480.60.77
0.220.030.470.02-0.140.030.2-0.310.030.38-0.050.32-0.10.020.34-0.210.38-0.240.3-0.010.0-0.09-0.35-0.07-0.25
-0.08-0.410.14-0.98-0.770.03-0.320.191.0-0.140.760.68-0.231.0-0.2-0.30.150.160.49-0.41-0.23-0.45-0.32-0.4-0.51
0.960.250.530.250.370.2-0.32-0.44-0.310.55-0.24-0.330.79-0.340.60.34-0.46-0.35-0.54-0.31-0.110.740.46-0.320.44
-0.410.04-0.67-0.14-0.13-0.310.19-0.440.19-0.960.18-0.120.020.2-0.960.020.260.130.30.16-0.24-0.440.080.180.01
-0.07-0.410.14-0.98-0.760.031.0-0.310.19-0.140.760.67-0.211.0-0.2-0.290.150.160.49-0.42-0.24-0.44-0.31-0.4-0.49
0.560.120.680.10.160.38-0.140.55-0.96-0.14-0.190.080.15-0.140.980.15-0.24-0.06-0.25-0.220.080.470.08-0.260.13
-0.09-0.360.14-0.79-0.49-0.050.76-0.240.180.76-0.190.42-0.210.73-0.15-0.30.0-0.120.12-0.34-0.4-0.22-0.26-0.27-0.39
-0.15-0.640.46-0.65-0.910.320.68-0.33-0.120.670.080.42-0.580.67-0.02-0.540.120.130.42-0.530.3-0.26-0.62-0.56-0.83
0.770.46-0.060.20.4-0.1-0.230.790.02-0.210.15-0.21-0.58-0.230.180.55-0.24-0.18-0.29-0.13-0.280.440.7-0.160.65
-0.1-0.360.1-0.97-0.770.021.0-0.340.21.0-0.140.730.67-0.23-0.21-0.250.170.230.52-0.41-0.22-0.45-0.28-0.4-0.47
0.570.150.680.140.250.34-0.20.6-0.96-0.20.98-0.15-0.020.18-0.210.17-0.3-0.13-0.38-0.190.020.540.11-0.210.19
0.30.86-0.220.280.47-0.21-0.30.340.02-0.290.15-0.3-0.540.55-0.250.17-0.250.61-0.25-0.14-0.40.490.96-0.190.89
-0.420.14-0.380.01-0.120.380.15-0.460.260.15-0.240.00.12-0.240.17-0.3-0.25-0.060.880.490.16-0.69-0.390.43-0.28
-0.30.43-0.27-0.14-0.16-0.240.16-0.350.130.16-0.06-0.120.13-0.180.23-0.130.61-0.060.18-0.26-0.110.010.47-0.320.3
-0.4-0.03-0.31-0.33-0.460.30.49-0.540.30.49-0.250.120.42-0.290.52-0.38-0.250.880.180.220.15-0.76-0.40.14-0.42
-0.440.16-0.510.480.59-0.01-0.41-0.310.16-0.42-0.22-0.34-0.53-0.13-0.41-0.19-0.140.49-0.260.220.02-0.49-0.190.980.18
-0.16-0.370.090.28-0.240.0-0.23-0.11-0.24-0.240.08-0.40.3-0.28-0.220.02-0.40.16-0.110.150.02-0.05-0.39-0.05-0.46
0.660.30.510.340.35-0.09-0.450.74-0.44-0.440.47-0.22-0.260.44-0.450.540.49-0.690.01-0.76-0.49-0.050.56-0.460.45
0.410.77-0.240.270.48-0.35-0.320.460.08-0.310.08-0.26-0.620.7-0.280.110.96-0.390.47-0.4-0.19-0.390.56-0.220.91
-0.450.13-0.490.450.6-0.07-0.4-0.320.18-0.4-0.26-0.27-0.56-0.16-0.4-0.21-0.190.43-0.320.140.98-0.05-0.46-0.220.16
0.340.84-0.280.460.77-0.25-0.510.440.01-0.490.13-0.39-0.830.65-0.470.190.89-0.280.3-0.420.18-0.460.450.910.16
Click cells to compare fundamentals

Cocrystal Pharma Account Relationship Matchups

Cocrystal Pharma fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets54.2M79.4M40.8M31.3M35.9M68.2M
Total Current Liabilities1.4M1.5M1.2M3.3M2.9M2.7M
Total Stockholder Equity52.5M77.5M39.6M26.4M30.3M42.6M
Net Debt(32.4M)(58.2M)(36.8M)(24.5M)(22.1M)(20.9M)
Retained Earnings(244.9M)(259.1M)(297.9M)(315.9M)(284.3M)(270.1M)
Accounts Payable657K578K614K1.2M1.4M931.8K
Cash33.0M58.7M37.1M26.4M30.3M31.8M
Non Current Assets Total20.2M20.1M662K2.2M2.5M2.4M
Cash And Short Term Investments33.0M58.7M37.1M26.4M30.3M31.8M
Common Stock Shares Outstanding55.2M88.4M8.1M9.7M11.1M13.1M
Liabilities And Stockholders Equity54.2M79.4M40.8M31.3M35.9M68.2M
Other Stockholder Equity297.3M336.5M337.5M342.3M393.6M413.3M
Total Liab1.7M1.8M1.3M4.9M4.4M4.2M
Total Current Assets34.0M59.3M40.2M29.1M33.5M35.1M
Common Stock71K98K8K10K11.5K10.9K
Other Current Liab267K495K122K1.8M1.6M1.7M
Property Plant And Equipment Net1.1M931K616K2.1M2.4M2.6M
Other Current Assets449K618K2.3M1.8M2.1M2.2M
Property Plant And Equipment Gross1.1M2.4M2.2M3.9M4.5M4.7M
Short Long Term Debt Total596K534K297K1.9M1.7M1.6M
Net Receivables556K0.0716K890K1.0M726.3K
Non Current Liabilities Total379K298K57K1.6M1.5M1.4M
Short Term Debt434K472K480K240K216K205.2K
Net Tangible Assets6.6M33.4M58.5M39.6M35.6M34.6M
Other Assets544K46K0.01.00.90.86
Property Plant Equipment1.1M1.1M931K616K708.4K640.6K
Net Invested Capital52.5M77.5M39.6M26.4M23.7M45.1M

Additional Tools for Cocrystal Stock Analysis

When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.